Prestige Biologics scraps share consolidation plan after shareholder vote fails

Bitget2026/09/30 09:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Prestige Biologics scrapped its planned share consolidation after shareholders voted down the proposal at the Sept. 30 annual meeting.
The vote also rejected a related charter amendment to change the par value per share, removing the basis for the consolidation.
The consolidation had been set by a Sept. 11 board resolution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930901099), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Prestige Biologics scraps share consolidation plan after shareholder vote fails

You may also like

Crypto prices